Overview
Foix-Chavany-Marie syndrome (FCMS), also known as bilateral anterior opercular syndrome or opercular syndrome, is a rare neurological condition characterized by the loss of voluntary control of the muscles of the face, tongue, pharynx, and jaw (facio-pharyngo-glosso-masticatory diplegia), while automatic and reflexive movements of these same muscles are preserved. This dissociation between voluntary and involuntary motor control is the hallmark of the syndrome. It results from bilateral damage to the anterior opercular region of the brain (the area surrounding the Sylvian fissure in the frontal and parietal lobes), which can be caused by strokes (most commonly), infections, epilepsy, or developmental malformations. Key symptoms include an inability to voluntarily move the face, tongue, and pharyngeal muscles, leading to severe difficulties with speech (anarthria), swallowing (dysphagia), and chewing. Patients may drool and have difficulty protruding the tongue or closing the mouth on command. However, these same patients can often smile spontaneously, yawn, cry, or cough normally because these automatic movements are controlled by different neural pathways. In some cases, particularly in children, the syndrome may be associated with epilepsy (Worster-Drought syndrome or congenital form). The condition can present in both acquired (adult) and developmental (childhood) forms. There is no specific curative treatment for Foix-Chavany-Marie syndrome. Management is supportive and multidisciplinary, focusing on speech therapy, swallowing rehabilitation, nutritional support (which may include nasogastric or gastrostomy feeding in severe cases), and treatment of the underlying cause when possible. In cases associated with epilepsy, antiepileptic medications may be beneficial. Prognosis varies depending on the underlying etiology; some patients may show partial recovery, particularly when the cause is vascular, while developmental forms tend to have a more persistent course.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Foix-Chavany-Marie syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Foix-Chavany-Marie syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Foix-Chavany-Marie syndrome.
Community
No community posts yet. Be the first to share your experience with Foix-Chavany-Marie syndrome.
Start the conversation →Latest news about Foix-Chavany-Marie syndrome
No recent news articles for Foix-Chavany-Marie syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Foix-Chavany-Marie syndrome
What is Foix-Chavany-Marie syndrome?
Foix-Chavany-Marie syndrome (FCMS), also known as bilateral anterior opercular syndrome or opercular syndrome, is a rare neurological condition characterized by the loss of voluntary control of the muscles of the face, tongue, pharynx, and jaw (facio-pharyngo-glosso-masticatory diplegia), while automatic and reflexive movements of these same muscles are preserved. This dissociation between voluntary and involuntary motor control is the hallmark of the syndrome. It results from bilateral damage to the anterior opercular region of the brain (the area surrounding the Sylvian fissure in the fronta
How is Foix-Chavany-Marie syndrome inherited?
Foix-Chavany-Marie syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Foix-Chavany-Marie syndrome?
15 specialists and care centers treating Foix-Chavany-Marie syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.